High-flying biotech Intercept Pharmaceuticals (ICPT) enjoyed a 516% gain last week, but shares have tumbled this week. After yesterday's 18% dive, shares dropped another 30% today. In the following video, analyst Max Macaluso discusses what caused today's drop and the key issues that long-term investors need to focus on.